Lv4
672 积分 2024-07-04 加入
Real-World Outcomes of Everolimus and Exemestane for the Treatment of Metastatic Hormone Receptor-Positive Breast Cancer in Patients Previously Treated With CDK4/6 Inhibitors
1天前
待确认
Clinical and molecular characteristics of HER2-low-positive breast cancer: pooled analysis of individual patient data from four prospective, neoadjuvant clinical trials
1天前
已完结
Antibody-drug conjugates for cancer
3天前
已完结
Impact of Baseline and On-Treatment Glycemia on Everolimus-Exemestane Efficacy in Patients with Hormone Receptor-Positive Advanced Breast Cancer (EVERMET)
7天前
已完结
Cyclic fasting-mimicking diet in cancer treatment: Preclinical and clinical evidence
7天前
已完结
Early downmodulation of tumor glycolysis predicts response to fasting-mimicking diet in triple-negative breast cancer patients
7天前
已完结
穿支螺旋桨皮瓣专家共识
8天前
已完结
中国晚期乳腺癌规范诊疗指南（2024版）
12天前
已完结
Overall survival with sacituzumab govitecan in hormone receptor-positive and human epidermal growth factor receptor 2-negative metastatic breast cancer (TROPiCS-02): a randomised, open-label, multicentre, phase 3 trial
13天前
已完结
Inavolisib-Based Therapy in PIK3CA-Mutated Advanced Breast Cancer
14天前
已完结
皖公网安备34019202002308
